Simple Summary The accumulated evidence on the role of epigenetic markers of prognosis in clear cell renal cell carcinoma (ccRCC) is reviewed, as well as state of the art on …
S Traynor, NE Møllegaard, MG Jørgensen… - Nucleic Acids …, 2019 - academic.oup.com
Rearrangement of the 1q12 pericentromeric heterochromatin and subsequent amplification of the 1q arm is commonly associated with cancer development and progression and may …
Heterochromatin is a transcriptionally repressive chromatin architecture that has a low abundance of genes but an enrichment of transposons. Defects in heterochromatin can …
D Drongitis, L Verrillo, P De Marinis, P Orabona… - International Journal of …, 2022 - mdpi.com
Glioblastoma multiforme (GBM) is a fatal brain tumor without effective drug treatment. In this study, we highlight, for the first time, the contribution of chromatin remodeling gene Lysine …
S Storvall, E Ryhänen, A Karhu, C Schalin-Jäntti - Cancers, 2023 - mdpi.com
Simple Summary Recently, PRUNE2 mutations were indicated in the pathogenesis of aggressive parathyroid neoplasms. Here, we report novel, rare PRUNE2 mutations located …
Y Hou, Y Yuan, Y Li, L Wang, J Hu, X Liu - Molecular Biology Reports, 2023 - Springer
Renal cell carcinoma accounts for 2–3% of all cancers. It is difficult to diagnose early. Recently, genome-wide studies have identified that histone methylation was one of the …
J Angulo Cuesta, C Manini, JI López, A Pueyo… - 2021 - ebuah.uah.es
Clear cell renal cell carcinoma (ccRCC) is curable when diagnosed at an early stage, but when disease is non-confined it is the urologic cancer with worst prognosis. Antiangiogenic …